🇺🇸 FDA
Company

Theravance

Theravance Biopharma

TBPH biotech USA

Quick answer

Theravance is a biotech company (TBPH) headquartered in GEORGE TOWN, GRAND CAYMAN, CA, USA with 24 tracked pipeline programs.

Pipeline (24)

project

Revefenacin

Chronic Obstructive Pulmonary Disease, COPD

Phase 3 · small_molecule · completed

2 trials project

TD-1473 Dose A

Ulcerative Colitis (UC)

Phase 3 · small_molecule · terminated

2 trials project

TD-4208

Chronic Obstructive Pulmonary Disease (COPD)

Phase 3 · small_molecule · completed

4 trials project

ampreloxetine

Symptomatic Neurogenic Orthostatic Hypotension

Phase 3 · small_molecule · active

4 trials project

400 microgrammes GSK961081

Pulmonary Disease, Chronic Obstructive

Phase 2 · small_molecule · completed

1 trials project

Placebo

Crohn's Disease

Phase 2 · small_molecule · terminated

1 trials project

Placebo

Chronic Obstructive Pulmonary Disease, COPD

Phase 2 · small_molecule · completed

1 trials project

Revefenacin Inhalation Solution [Yupelri]

COPD

Phase 2 · small_molecule · completed

1 trials project

TD-0903

Acute Lung Injury (ALI) Associated With COVID-19

Phase 2 · small_molecule · completed

2 trials project

TD-1211

Opioid-induced Constipation (OIC)

Phase 2 · small_molecule · completed

1 trials project

TD-1211

Opioid Induced Constipation

Phase 2 · small_molecule · completed

2 trials project

TD-1211

Healthy

Phase 2 · small_molecule · completed

2 trials project

TD-1792

Staphylococcal Skin Infection

Phase 2 · small_molecule · completed

1 trials project

TD-4208

Chronic Obstructive Pulmonary Disease

Phase 2 · small_molecule · completed

1 trials project

TD-4208

COPD

Phase 2 · small_molecule · completed

2 trials project

TD-5108

Chronic Constipation

Phase 2 · small_molecule · completed

1 trials project

TD-8236

Asthma

Phase 2 · small_molecule · completed

2 trials project

TD-9855

Attention-Deficit/Hyperactivity Disorder

Phase 2 · small_molecule · completed

1 trials project

TD-9855

Neurogenic Orthostatic Hypotension

Phase 2 · small_molecule · completed

1 trials project

TD-9855 Group 1

Fibromyalgia

Phase 2 · small_molecule · completed

1 trials project

Telavancin

Infection

Phase 2 · small_molecule · completed

1 trials project

Velusetrag

Gastroparesis

Phase 2 · small_molecule · completed

1 trials project

velusetrag dose 1

Gastroparesis

Phase 2 · small_molecule · completed

1 trials project

Ampreloxetine

Symptomatic Neurogenic Orthostatic Hypertension

Phase 1 · small_molecule · completed

1 trials

Drugs (1)

drug

telavancin

VIBATIV

Patents (8)

patent

US 12384761

Imidazolo indazole compounds as JAK inhibitors

Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12358931

3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amin

Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12351561

Crystalline (2S,4R)-5-(5'-chloro-2'-fluoro-[1,1'-biphenyl]-4-yl)-2-(ethoxymethyl

Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12285417

Methods for treating chronic obstructive pulmonary disease

Expires Mon Apr 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12258316

Biphenyl compounds useful as muscarinic receptor antagonists

Expires Mon Mar 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12239638

Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound

Expires Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12172994

Pyrimidine compound as JAK kinase inhibitor

Expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12122773

Crystalline hydrate of a JAK inhibitor compound

Expires Mon Oct 17 2044 00:00:00 GMT+0000 (Coordinated Universal Time)